Imarat
Pharmaceutical companies in India

Roche Diabetes Care India launches app for blood glucose monitoring

Roche Diabetes Care India launches app
6 122
From Left to Right Dr Shashank Joshi, and Gaurav Laoria

 DTMT Network
Roche Diabetes Care (RDC) India, pioneering innovative diabetes technologies, has launched two apps including “mySugr” and “Accu-Chek Instant” blood glucose monitoring system, which together form the next generation blood glucose monitoring system.

Together, the mySugr App and Accu-Chek Instant bring advanced connectivity and accuracy to help people with diabetes (PwDs) effortlessly manage their blood sugar levels and spend more time in range.

The ‘mySugr’ provides bluetooth connectivity with Accu-Chek Instant, enabling the automatic uploading of data. The app provides easy access to blood glucose monitoring data to caregivers and doctors, enabling dynamic therapy modification. Through this app, users also have access to diabetes coaching at their fingertips.

Dr. Gaurav Laroia, General Manager, Roche Diabetes Care India, said that this integrated platform allows patients, caregivers, and healthcare professionals to view, share, and access blood glucose data anytime for timely advice, and optimised treatment decisions.

"My mantra to prevent diabetes for Indians is eat less, walk more, monitor regularly, sleep well and smile", Dr Shashank Joshi, Endocrinologist, President, Indian Academy of diabetes Chair (elect) IDF South east Asia.

Dr. Varsha Khatry, Head – Medical & Scientific Affairs, RDC, said that RDC India has taken a step ahead by setting up the Center of Excellence where the healthcare workers will be trained on the “Integrated Diabetes Management – IDM”.

IDM model will improve the physician-patient-dialogue, patient and physician satisfaction, patient adherence and glycemic control. It will also enable patients to master the complexity of managing diabetes to improve “Time in Range".


0 Comments

  1. Be first to post your comments

Your Comment

Your email address will not be published. Required fields are marked *

2+3

Back to Top